More than 50% of participants in NIH funded research studies in 1997 were women. Health spending 1993-99 grew 39% for women & 23% for men. NIH Increased Its Efforts to Include Women in Research. Women Sufficiently Represented in New Drug Testing, FDA Oversight Needs Improvement. FDA has not effectively overseen the presentation and analysis of data related to sex differences in drug development.

File Type: pdf
File Size: 235 KB
Categories: Health, Health Disparities
Tags: Applications, Clinical, Data, Drug, Enrollment, Extramural, Fda, GAO, Health, Minority, NIH, Participants, Policy, Research, sex, Studies, Trials, Women